A specific polarisation fluoroimmunoassay for the measurement of paracetamollevels in serum has been developed for use in emergency toxicological screening. It is based on the use of a fluorescein-labelled analogue and a sheep antiserum and exploits the rapid dissociation kinetics of the hapten-antibody complex to enable the label and antiserum to be combined as a single reagent. Paracetamollevels are determined by adding 5 I1L of serum to 1·5 mL of the single reagent, incubation at ambient temperature for a few minutes and measurement of fluorescence polarisation. In addition to its speed and simplicity, the assay is both accurate and precise and the results obtained correlate closely with those from the commonly used chemical and enzymatic techniques.
Paracetamol is widely used as an effective analgesic which is available either alone or combined with dextropropoxyphene. However, since the first cases of paracetamol-induced hepatic damage were described in 1966, there has been a rapid increase in paracetamol related admissions and there are now some 200 deaths each year in the United Kingdom attributable to this drug. Fortunately, effective antidotes have been introduced and good management is facilitated by the availability of rapid serum assays sufficiently simple for use in an emergency. I Several methods are available for the measurement of serum levels of paracetamol of which the nitration method introduced by Glynn and Kendal 2 based on a reaction first used by Chafetz' has been the most widely used, with a modification to reduce interference by salicylate." Recently simpler methods have been introduced including an enzymatic procedure.l an enzymoimmunoassay (EMIT) (Syva) Syntex Pharmaceuticals Ltd, Maidenhead, Berks, UK and a polarisation fluoroimmunoassay (PFIA) (Abbott TDx, Abbott Laboratories Ltd, Esher, Surrey, UK). The enzymatic technique is the most commonly used method in the United Kingdom, paracetamol being hydrolysed to p-aminophenol and acetate by a microbial aryl acylamidase and the p-aminophenol reacted with o-cresol and Correspondence: Ruth Coxon. ammoniacal copper sulphate to form an indophenol dye which is determined colorimetrically.
In 1976, the first clinically relevant PFIA was introduced for the accurate quantification of serum levels of gentamicin" followed by an assay for phenytoin.' Several years later Abbott introduced their TDx system which is based on PFIA. More recently, based on a study of hapten:antibody binding, the technique has been further simplified by combining the labelled-hapten and antiserum as a single reagent. This single reagent approach is being applied to the detection of drugs of abuse in urine" 10 and it is intended to extend the technique to drugs of toxicological importance and to other compounds of relevance in clinical chemistry such as metanephrine. This paper describes the development of a specific single reagent PFIA for the measurement of paracetamol in serum." A number of different immunogens and fluorophore-labelled analogues were synthesised and studied before obtaining an antiserum and label suitable for clinical use, as described elsewhere. II
Materials and methods
Assay buffer: sodium borate buffer (100 mmoV L, pH 9·2) containing sodium dodecyl sulphate (SDS) (222 mgIL), Triton x-roo (488 mg/L) and sodium azide (t·O giL). Antiserum was from a sheep immunised with p-aminophenol hemisuccinide conjugated to keyhole limpet haemacyanin (KLH) as described elsewhere. II Fluorescein-labelled p-caprylamidophenol, prepared as described elsewhere," was employed as labelled analyte. The single reagent was prepared by mixing fluorescein-labelled paracetamol (10 nmoVL) and anti-paracetamol serum (diluted SOOO-fold) in assay buffer. It was stored at 4°C in the dark and was stable for at least 4 months.
Assay standards: a solution of paracetamol in ethanol (Ig/L) was added to drug-free human serum to give a stock serum standard (800 mg/L 
Polarisation fluoroimmunoassay
The assay is performed in glass cuvettes (Abbott Diagnostics Division, Basingstoke, Hants, UK) in duplicate at ambient temperature. Undiluted serum or standard (S ItL) is added to 1·5 mL of single reagent, mixed, incubated for 5 min and the fluorescence polarisation measured using a Model 4000 polarisation fluorimeter (SLM Instruments, Urbana, IL 61801) as previously described.F MODIFIED GLYNN KENDAL METHOD Proteins are precipitated by adding 2·0 mL of 10% TeA to 1·0 mL of sample, standard or distilled water (blank). The tubes are mixed thoroughly, stoppered, centrifuged and 0·5 mL of 6M hydrochloric acid added to the supernatant followed by 0·5 mL of freshly prepared 10% sodium nitrite. The solution is mixed well and allowed to stand for 5 min when ammonium sulphamate (0,5 mL) is added slowly with swirling during which time the solution effer-vesces. Finally, 2·5 mL of J()% sodium hydroxide is added, the solution mixed and the colour read at 430 nm within I h.
QUANTASE ACETAMINOPHEN, PARACETAMOL ASSAY
The assay was performed according to the manufacturer's instructions (Porton Products Limited, P.O. Box 85, Wrexham, Clwyd, Wales). Enzyme reagent (1 mL) is mixed with 50 ilL of sample, standard or distilled water (blank). After incubation at ambient temperature for 3 min, I mL of colour reagent A is added followed by 1 mL of colour reagent B. The tubes are mixed and incubated at room temp for 2 min and the absorbance read at 615 nm.
Results
The association kinetics were determined by mixing the label and antibody at the concentrations required for the assay and measuring the increase in fluorescence polarisation at 15 s, 30 sand 60 s. At these times, 93·2%, 94·5% and 96·3% respectively of the labelled hapten was bound (Figs lA and 18 ). The dissociation kinetics were determined by the technique previously described" in which a large excess of unlabelled paracetamol is added to pre-equilibrated label and antibody and the decrease in fluorescence polarisation measured. (Figs lA and IB). The polarisation half life was 30 s for the fast (58%) dissociating antibody populations. The presence of these fast dissociating populations enabled the label and antibody to be pre-mixed and used as a single reagent.
A standard curve was obtained that covered the clinically relevant range (Fig. 2) .
In detergent-free buffer there was significant binding of the labelled drug by serum proteins as evidenced by elevated polarisation readings (75 mp in buffer alone and 308 mp with added (5 ilL) drug-free serum). This problem was resolved by adding SDS and Triton X-loo to the buffer when polarisation readings for labelled drug in buffer alone and with added serum were 75 mp and 76 mp respectively.
The sensitivity was calculated from the results of 20 replicates at zero dose using Rodbard's method.P The minimal detectable concentration was 2 mg/L with 95% confidence limits.
Three pools of serum, prepared at concentrations of 25 mg/L, 75 mglL and 280 mg/L, and measured 10 times in one assay gave within- assay coefficients of variation (CV) of 4·3%. 7·7% and 5·4% respectively. Between-assay CV's calculated from results obtained after the same specimens had been assayed on 10 dif-ferent days were 10·8%. 1·6% and 5·9%, respectively. Paracetamol in drug-free human serum was added to patients' serum samples with initial paracetamol levels of 40, 80, and 150 mg/L. Analytical recovery of 50, 125. and 150 mg/L of added paracetamol was 90%, 92% and 92%, respectively.
The glucuronide, sulphate, N-acetyl-cysteinyl and L-cysteinyl metabolites of paracetamol, salicylate, 4-amino salicylate, acetyl salicylate, propoxyphene, dihydrocodeine, codeine phosphate, methyl salicylate, chlordiazepoxide and diflunisal showed no cross reaction when tested in the assay at 1 giL.
Paracetamol was added to visually haemolysed and lipaemic samples at 125 and 250 mgIL. Analytical recovery in the haemolysed samples was 80% and 88%. whereas in the lipaemic samples it was reduced to 64% at both levels.
Samples from 25 patients' were measured by PFIA and the results compared to those obtained when the same samples were measured by the enzymatic method and by the modified nitration method. With the enzymatic technique, y=0·896x+6·2 with a correlation coefficient (r)=O·986. with the Glynn Kendal technique y=0·875x-7·2 and r=0·961. Comparison of the enzyme-based method (x) and the modified nitration method gave y=I'03l+ 13·7 and r=0·970. 
Discussion
An assay for the measurement of paracetamol in an emergency situation should be simple, rapid and specific for the parent drug. By exploiting the rapid dissociation characteristics of the labelled hapten and antiserum used, an assay was developed which involved only addition of patients' serum to a pre-mixed reagent, incubation for 5 min at ambient temperature and measurement of fluorescence polarisation. This protocol takes less than 15 min to complete and compares favourably with the enzymic method and especially the modified nitration method. The assay is specific for the parent drug as evidenced by the cross-reactivity studies and addition of Triton X-l00 and SDS to the assay buffer effectively prevented non-specific binding of the label to serum proteins. Although there was no significant change interference from haemolysis, ideally a fresh, unhaemolysed sample should be obtained. For lipaemic samples a blank can be performed. 12 Results by the PFIA assay were compared to those by the two most commonly used assays. The correlation with the enzymatic method was slightly better (r=O·986) than with the modified nitration method (r=O'961) which may reflect a lack of specificity of the latter. Fluorescence polarisation measurements are very temperature dependent so that, with the fluorimeter used in this study which lacked adequate temperature control, it was necessary to set up a full standard curve with each batch of assays.
